UK – Access, new active substance and biosimilar work sharing initiatives
The New Active Substance Work Sharing Initiative (NASWSI) has successfully approved several medicines through this international collaboration and continues to foster cooperation and strong relationships between its Access partners. The Biosimilar Work Sharing Initiative (BSWSI) builds on this success.
By engaging in these partnerships, Access is able to co-ordinate regulatory review procedures, and increase each agency’s capacity to ensure consumers have timely access to high quality, safe and effective therapeutic products.
More information on the MHRA Website.
OpenEdition vous propose de citer ce billet de la manière suivante :
vroby (26 mars 2025). UK – Access, new active substance and biosimilar work sharing initiatives. ELSIBI. Consulté le 5 mars 2026 à l’adresse https://doi.org/10.58079/13knm





